NasdaqCM - Delayed Quote USD

KALA BIO, Inc. (KALA)

4.3800
-0.3600
(-7.59%)
At close: 4:00:01 PM EDT
4.3200
-0.06
(-1.37%)
After hours: 4:09:06 PM EDT

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue --
Earnings -6.43M

Q2'24

Q3'24

Q4'24

Q1'25

-8M
-6M
-4M
-2M
0
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

12.00
13.50 Average
4.3800 Current
15.00 High

Earnings Estimate

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
No. of Analysts 111--
Avg. Estimate -2.04-1.11-5.460
Low Estimate -2.04-1.11-5.460
High Estimate -2.04-1.11-5.460
Year Ago EPS -2.45-1.93-7.46--

Revenue Estimate

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
No. of Analysts 2221
Avg. Estimate --------
Low Estimate --------
High Estimate --------
Year Ago Sales --------
Sales Growth (year/est) 0.00%0.00%0.00%0.00%

Earnings History

Currency in USD 6/30/2024 9/30/2024 12/31/2024 3/31/2025
EPS Est. -4.58-2.71-2.47-2.54
EPS Actual -2.45-1.93-1.23-1.01
Difference 2.130.781.241.53
Surprise % 46.61%28.78%50.14%60.11%

EPS Trend

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
Current Estimate -2.04-1.11-5.460
7 Days Ago -2.74-1.29-7.070
30 Days Ago -2.74-1.29-7.070
60 Days Ago -1.3-1.29-6.020
90 Days Ago -1.3-1.29-6.020

EPS Revisions

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days 111--
Up Last 30 Days 111--
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
KALA 16.58%42.49%26.83%--
S&P 500 13.13%2.46%7.54%14.07%

Upgrades & Downgrades

Maintains HC Wainwright & Co.: Buy to Buy 5/23/2025
Reiterates HC Wainwright & Co.: Buy to Buy 4/4/2025
Reiterates HC Wainwright & Co.: Buy to Buy 2/13/2025
Reiterates HC Wainwright & Co.: Buy to Buy 11/15/2024
Reiterates Oppenheimer: Outperform to Outperform 8/19/2024
Maintains HC Wainwright & Co.: Buy to Buy 5/17/2024

Related Tickers